Nestlé successfully completed acquisition of Aimmune Therapeutics
THE FINANCIAL -- Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé ...
ADVERTISEMENT
Tag: Aimmune’s Palforzia
Nestle announced the results of the tender offer for Aimmune
The FINANCIAL -- Société des Produits Nestlé S.A. ("Nestlé") today announced the results of the tender offer by its wholly-owned ...
Nestle to buy Aimmune’s peanut allergy treatment at $2.6 billion
The FINANCIAL -- Nestle agreed to buy Aimmune Therapeutics Inc. for $2.6 billion, adding a promising peanut allergy treatment to its ...
Popular Last 24h
How to Check KRA Pin Using ID Number
7 Simple and Effortless Home Loan Options for Retirees
CEO Of Immigration Services Company Sentenced To 10 Months In Prison Following Trial Conviction For Immigration Fraud Offenses
57% globally think their country is not doing enough to meet its infrastructure needs
Gartner Forecasts Global Security and Risk Management Spending to Grow 14% in 2024
Gartner Says 80% of Supply Chain Not Accounted for in Current Digital Decision Models
LATEST POSTS
LATEST INTERVIEWS
ADVERTISEMENT
